Functionalization of endogenous bacteria
US9957511B2 · kind B2 · utility
1Cited by
1References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 1, 2014 |
| Grant date | May 1, 2018 |
| Priority date | — |
| Expiry date | Jul 1, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Various aspects and embodiments of the present disclosure are directed to methods and compositions for functionalizing endogenous bacteria in vivo. The methods include delivering to endogenous bacterial cells a recombinant bacteriophage or phagemid that is engineered to contain at least one genetic circuit.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.